BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35518809)

  • 41. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.
    Singh RP; Farney AC; Rogers J; Zuckerman J; Reeves-Daniel A; Hartmann E; Iskandar S; Adams P; Stratta RJ
    Clin Transplant; 2011; 25(2):255-64. PubMed ID: 20331689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Outcomes of Liver Transplantation Using Donors After Circulatory Death in Patients With Hepatocellular Carcinoma: A Comparative Study.
    Martinez-Insfran LA; Ramirez P; Cascales P; Alconchel F; Ferreras D; Febrero B; Martinez M; González MR; Sanchez-Bueno F; Robles R; Parrilla P
    Transplant Proc; 2019 Mar; 51(2):359-364. PubMed ID: 30879541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
    Mazilescu LI; Kotha S; Ghanekar A; Lilly L; Reichman TW; Galvin Z; Cattral MS; Bhat M; McGilvray ID; Sapisochin G; Sayed B; Selzner M; Selzner N
    Transplant Direct; 2021 Aug; 7(8):e727. PubMed ID: 34291149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donation after circulatory death is associated with increased fibrosis on 1-year post-transplant kidney allograft surveillance biopsy.
    van der Windt DJ; Mehta R; Jorgensen DR; Hariharan S; Randhawa PS; Sood P; Molinari M; Wijkstrom M; Ganoza A; Tevar AD
    Clin Transplant; 2021 Sep; 35(9):e14399. PubMed ID: 34176169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M; Liwinski T; Adam R; Berenguer M; Mirza D; Malek-Hosseini SA; Heneghan MA; Lodge P; Pratschke J; Boudjema K; Paul A; Zieniewicz K; Fronek J; Mehrabi A; Acarli K; Tokat Y; Coker A; Yilmaz S; Karam V; Duvoux C; Lohse AW; Schramm C;
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.
    Scalea JR; Redfield RR; Foley DP
    Liver Transpl; 2016 Sep; 22(9):1197-204. PubMed ID: 27314220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
    Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney donation after circulatory death (DCD): state of the art.
    Summers DM; Watson CJ; Pettigrew GJ; Johnson RJ; Collett D; Neuberger JM; Bradley JA
    Kidney Int; 2015 Aug; 88(2):241-9. PubMed ID: 25786101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
    Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
    Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.
    Van Raemdonck D; Keshavjee S; Levvey B; Cherikh WS; Snell G; Erasmus M; Simon A; Glanville AR; Clark S; D'Ovidio F; Catarino P; McCurry K; Hertz MI; Venkateswaran R; Hopkins P; Inci I; Walia R; Kreisel D; Mascaro J; Dilling DF; Camp P; Mason D; Musk M; Burch M; Fisher A; Yusen RD; Stehlik J; Cypel M;
    J Heart Lung Transplant; 2019 Dec; 38(12):1235-1245. PubMed ID: 31777330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results in liver transplantation using grafts from donors after controlled circulatory death: A single-center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death.
    Otero A; Vázquez MA; Suárez F; Pértega S; Rivas JI; Mosteiro F; Gómez M
    Clin Transplant; 2020 Jan; 34(1):e13763. PubMed ID: 31808579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.
    Pan X; Apinyachon W; Xia W; Hong JC; Busuttil RW; Steadman RH; Xia VW
    Liver Transpl; 2014 Jul; 20(7):823-30. PubMed ID: 24711100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donation after circulatory death liver transplantation: What are the limits for an acceptable DCD graft?
    Kubal C; Roll GR; Ekser B; Muiesan P
    Int J Surg; 2020 Oct; 82S():36-43. PubMed ID: 32389812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death.
    Nagaraja P; Roberts GW; Stephens M; Horvath S; Fialova J; Chavez R; Asderakis A; Kaposztas Z
    Transplantation; 2012 Dec; 94(12):1218-23. PubMed ID: 23154212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recipient and allograft survival following donation after circulatory death versus donation after brain death for renal transplantation: A systematic review and meta-analysis.
    Gavriilidis P; Inston NG
    Transplant Rev (Orlando); 2020 Oct; 34(4):100563. PubMed ID: 32576429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.